Catherine McNamara

Catherine McNamara, PharmD, BCPS, is a clinical pharmacogenomics specialist at an academic medical center in Boulder, Colorado. She directs a clinical testing service focused on gene-based dosing and investigates how variations in CYP enzymes affect drug response and patient toxicity. McNamara received her PhD in pharmaceutical sciences from the University of California, San Francisco, and she contributes to Biology Insights on medication science.